- Incannex Healthcare | Innovating New Pathways to Relief
Incannex is a science-led combination medicines company focused on rapidly developing novel oral fixed-dose treatments and therapeutic regimens for people living with challenging chronic conditions
- Incannex Healthcare Inc. (IXHL) Stock Price, News, Quote History . . .
Incannex Healthcare Inc , a clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients
- News Releases | Incannex Healthcare
View Incannex Healthcare releases, including company news, investor relations information and more
- Incannex Healthcare (IXHL) Company Profile Description
Incannex Healthcare Inc , a clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia
- Incannex stock drops despite trial win for lead asset (IXHL)
Incannex Healthcare (IXHL) stock falls even as the company's lead asset IHL-42X achieves success in a Phase 2 trial for sleep apnea Read more here
- Nano-Cap Incannexs Sleep Apnea Candidate Shows . . . - Benzinga
Incannex's IHL-42X showed significant efficacy in Phase 2 sleep apnea trial, with strong AHI reduction, improved sleep, and no serious side effects
- Incannex Reports $50M Cash Position, Successful Phase 2 Results for IHL . . .
Incannex announces $50M cash position and limits ATM usage while reporting significant Phase 2 success for IHL-42X therapy Get full financial and clinical details
- About Incannex | Novel Therapies for Chronic Conditions
Incannex is a science-led combination medicines company leading the way in developing cannabinoid-based medicines and psychedelic-based regimens for people living with challenging chronic conditions
|